<
Chinese medicine companies do not have the ability to extract 2016
Release time: 2013-11-29 & nbsp & nbsp & nbsp Source: Anonymous

    Business Club November 29th Chinese Medicine Extract、Natural drugs strict management is about to begin。The State Food and Drug Administration recently issued the "Notice on Strengthening the Extraction and Extraction of Chinese Medicine",Strict specifications for this。
 
The state will vigorously rectify the Chinese medicine extraction industry
 
"Draft for Consultation",From January 1, 2016,Any Chinese medicine production enterprise that does not have the ability to extract Chinese medicine,All the production of the corresponding varieties will be stopped,The approved commission processing should also be abolished。Chinese medicine extracts that have obtained the drug approval number,After the validity period of the approval number expires,Provincial Food and Drug Administration will not register again。
 
Industry insiders pointed out,This file indicates that the state vigorously rectifies the Chinese medicine extraction industry,The raw materials are guaranteed to ensure the quality,Lay the foundation for improving the overall strength of my country's medicine in the future,It is also conducive to realizing the internationalization process of Chinese medicine。The Chinese medicine extraction industry is under the stake sports betting appinfluence Stake Sports Bettingof this policy,It may usher in a large -scale merger wave。
 
& ldquo; The purpose of the document is to use the guidance of the regulatory department,Improve the early communication mechanism,Enhanced the supervision of the drug research process and the clinical trial institution of the drug,Create a good innovation R & D environment、Contain low level repetition。& rdquo; An industry insider pointed out。
 
& ldquo; Strict approval,Thoughts of strengthening supervision & rdquo; comprehensively implemented in the "Draft for Soliciting Opinions",Including three aspects。
 
1 is from January 1, 2016,Any Chinese medicine production enterprise that does not have the ability to extract Chinese medicine,All the production of the corresponding varieties will be stopped,The approved commission processing should also be abolished。Second, the Chinese medicine extract of the drug approval number has been obtained,After the validity period of the approval number expires,Provincial Food and Drug Administration will not register again。Third is to download the item of the National Pharmaceutical Standards of Chinese Pharmaceuticals,Chinese medicine extracts with separate national drug standards,Implementation filing management。From January 1, 2015,All Chinese medicine extracts that have not been recorded as required are not allowed to be used for the production of Chinese medicines。
 
Domestic Chinese medicine extraction industry fish dragon mixed
 
Chinese medicine extract is the prescription item of Chinese medicine standards for Chinese medicines,Volatal Oil with a separate national drug standard、Oil、Perm、Streaming extract、dry extract、Effective ingredients、Effective parts and other components。Chinese medicine extraction is the key link of the production and quality management of Chinese medicine,Production enterprises must have an extraction ability that is compatible with its production varieties and scale。
 
According to Guo Fanli, Manager of the Research Department of China Investment Consultant Industry,Chinese medicine extracts have three uses in my country。1 is to do Chinese medicine,The current traditional Chinese medicine products are mostly admitted to stake online sports bettingStake Sports Bettingthe original medicinal materials or primary extracts; the second is the health food field,Domestic health food has continued the mode of Chinese medicine for a long time,The requirements for ingredients or logo are not high; third, functional food and daily cosmetics。

& ldquo; At present, the domestic Chinese medicine extraction industry is not as standard as Europe, America, Japan and South Korea,Fish and Dragon Mixed in the industry,The supervision is not strict and incomplete,Show scattered features。& rdquo; Guo Fanli told reporters。
 
Data display from the State Food and Drug Administration,At present, the approval number of domestic drugs reaches more than 160,000,Chinese medicine natural drugs account for more than 60,000。& ldquo; This is basically matched with Chinese medicine natural drugs accounting for one -third of the pharmaceutical market。& rdquo; An industry insider pointed out,After clearing the irrational declaration left by history,The average annual average of 20 & mdash has been approved for marketing since 2008,& ldquo; This number is not small,The key problem is that there are many problems with the overall approval of Chinese medicine & rdquo;。
 
It is reported,This is mainly reflected in: the advantages and characteristics of Chinese medicine have not been fully reflected,If you do not understand the advantages and characteristics of Chinese medicine、Inaccurate,Lack of scientific data to support the effectiveness and safety of drugs,Makes inadequate basis for the existence of the presence when applying for approval、Compound clinical basis、Inadequate screening of effective parts and composition、Lack of basic research and clinical efficacy research。At the same time,Enterprise's new indications against Chinese medicine、New research results and other innovative fields are not concerned,& ldquo; The enthusiasm of the second scientific research & rdquo; is not high,For medicinal materials、The impact of quality and resource sustainable use of the place of production Stake Sports Bettingstake sports betting appattaches not enough attention。
 
New policy improvement requirements are conducive to export of Chinese medicine
 
& ldquo; The improvement of the new policy is conducive to the export of Chinese medicine。& rdquo; An industry insider pointed out,Chinese medicine extract is the mainstream of Chinese medicine exports,Relevant departments are currently being revised by the 2015 version of "Chinese Pharmacopoeia",After the 2010 version of the Pharmacopoeia added 27 species,2015 version of the Pharmacopoeia plan to add 60 species of Chinese medicine extracts。Plant extract is the most likely to realize the internationalization sub -industry in the field of traditional Chinese medicine,New Deal will drive the quality of the product,Accelerate the internationalization process of Chinese medicine。
 
The plant extract industry is & ldquo; Chaoyang Industry & RDQUO;,Occupy the export ratio of Chinese medicine products is nearly half。2010 plant extract export value reached 820 million US dollars,In 2011, it exceeded the $ 1 billion mark。2012 Plant extracts and foreign trade increased slowly,Export value is 1.16 billion US dollars。In the first quarter of 2013, the import and export amount of plant extracts in my country was US $ 410 million,increased by 12.1%year -on -year,Among them, the export value is 330 million US dollars,increased by 11.2%year -on -year,47%of the export of Chinese medicine products.
 
Raising standards also means another & ldquo; you died and I live & rdquo;。"Economic Reference News" reporter learned,At present, listed companies engaged in Chinese medicine extracts,There is Kang Enbei、Taski、Jianfeng Group、Jiaotong University Angli、Rhine creatures, etc.。Kang Enbei is the earliest company in China to develop ginkgo -leaf preparations。Jiaotong University subsidiary is the largest domestic plant extract company,The main products are Luo Han Guo extract、Artemisinin, etc.。Rhine's biological leading products are red view extraction、Luo Han Guo extract, etc.,It is one of the companies that are capable of producing the most complete varieties stake online sports bettingstake betting appof plant extracts in China。
 
& ldquo; The original Chinese medicine extraction section fake hand -in -person big enterprise,To ensure that production must expand a new extract workshop or directly acquires small companies that do not meet the policy but have reached standards。& rdquo; Guo Fanli pointed out,The new policy is actually required to be responsible for the final product of production of Chinese medicine companies,Strengthen the construction of product quality management system,From raw material extraction to production to making medicines, they must be managed by the company。& ldquo; It is not easy for small companies to make all this。& rdquo;